4.8 Article

Synthesis of Enantioenriched α-Chiral Bicyclo[1.1.1]pentanes

期刊

ORGANIC LETTERS
卷 21, 期 7, 页码 2408-2411

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.orglett.9b00691

关键词

-

资金

  1. EPSRC Centre for Doctoral Training in Synthesis for Biology and Medicine [EP/L015838/1]
  2. AstraZeneca
  3. Diamond Light Source
  4. Defence Science and Technology Laboratory
  5. Evotec
  6. GlaxoSmithKline
  7. Janssen
  8. Novartis
  9. Pfizer
  10. Syngenta
  11. Takeda
  12. UCB
  13. Vertex
  14. EPSRC [EP/M019195/1, EP/S013172/1]
  15. EPSRC [EP/S013172/1] Funding Source: UKRI

向作者/读者索取更多资源

Bicyclo[1.1.1]pentanes (BCPs), useful surrogates for para-substituted arenes, alkynes, and tert-butyl groups in medicinal chemistry, are challenging to prepare when featuring stereogenic centers adjacent to the BCP. We report the development of an efficient route to alpha-chiral BCPs, via highly diastereoselective asymmetric enolate functionalization. We also describe the application of this chemistry to the synthesis of BCP analogues of phenylglycine and tarenflurbil, the single enantiomer of the NSAID flurbiprofen.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据